BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9166113)

  • 1. Jurkat cell proliferative activity is increased by luteinizing hormone-releasing hormone.
    Azad N; LaPaglia N; Kirsteins L; Uddin S; Steiner J; Williams DW; Lawrence AM; Emanuele NV
    J Endocrinol; 1997 May; 153(2):241-9. PubMed ID: 9166113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of luteinizing hormone releasing hormone (LHRH) and [D-Trp6, des-Gly-NH2(10)]LHRH ethylamide on alpha-subunit and LH beta messenger ribonucleic acid levels in rat anterior pituitary cells in culture.
    Hubert JF; Simard J; Gagné B; Barden N; Labrie F
    Mol Endocrinol; 1988 Jun; 2(6):521-7. PubMed ID: 2458526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
    Gründker C; Völker P; Schulz KD; Emons G
    Gynecol Oncol; 2000 Aug; 78(2):194-202. PubMed ID: 10926802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of human growth hormone-releasing hormone on the release of dynorphin-like immunoreactivity, luteinizing hormone, and follicle-stimulating hormone from rat adenohypophysis in vitro.
    Knepel W; Schwaninger M; Wesemeyer G; Döhler KD; Sandow J
    Endocrinology; 1987 Feb; 120(2):732-8. PubMed ID: 2879724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of castration on steady state levels of luteinizing hormone-releasing hormone (LHRH) mRNA and proLHRH processing: time course study utilizing semi-quantitative reverse transcription/polymerase chain reaction.
    Emanuele NV; Jurgens J; La Paglia N; Williams DW; Kelley MR
    J Endocrinol; 1996 Mar; 148(3):509-15. PubMed ID: 8778229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteinizing hormone-releasing hormone (LHRH) agonist restoration of age-associated decline of thymus weight, thymic LHRH receptors, and thymocyte proliferative capacity.
    Marchetti B; Guarcello V; Morale MC; Bartoloni G; Raiti F; Palumbo G; Farinella Z; Cordaro S; Scapagnini U
    Endocrinology; 1989 Aug; 125(2):1037-45. PubMed ID: 2546733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats.
    Kovacs M; Schally AV
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12197-202. PubMed ID: 11593037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of long-term treatment with the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl and the LHRH antagonist Cetrorelix on the levels of pituitary LHRH receptors and their mRNA expression in rats.
    Horvath JE; Bajo AM; Schally AV; Kovacs M; Herbert F; Groot K
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):15048-53. PubMed ID: 12409615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats.
    Pinski J; Lamharzi N; Halmos G; Groot K; Jungwirth A; Vadillo-Buenfil M; Kakar SS; Schally AV
    Endocrinology; 1996 Aug; 137(8):3430-6. PubMed ID: 8754771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LHRH stimulates plasminogen activator and inhibits steroid production by granulosa cells of adult rat Graafian follicles.
    Wang C; Leung A
    Mol Cell Endocrinol; 1986 Jan; 44(1):61-8. PubMed ID: 3081386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation by sex steroids and [D-Trp6, Des-Gly-NH2(10)]luteinizing hormone (LH)-releasing hormone ethylamide of alpha-subunit and LH beta messenger ribonucleic acid levels in the rat anterior pituitary gland.
    Simard J; Labrie C; Hubert JF; Labrie F
    Mol Endocrinol; 1988 Sep; 2(9):775-84. PubMed ID: 2459604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corelease of dynorphin-like immunoreactivity, luteinizing hormone, and follicle-stimulating hormone from rat adenohypophysis in vitro.
    Knepel W; Schwaninger M; Döhler KD
    Endocrinology; 1985 Aug; 117(2):481-7. PubMed ID: 2862008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The luteinizing hormone-releasing hormone (LHRH) agonist, [D-Trp6, des-Gly-NH2(10)]-LHRH ethylamide, has no direct effect on spermatogenesis in the rat.
    Dubé D; Pelletier G; Labrie F
    Biol Reprod; 1988 Jun; 38(5):1165-70. PubMed ID: 3044454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteinizing hormone-releasing hormone-binding sites in the rat thymus: characteristics and biological function.
    Marchetti B; Guarcello V; Morale MC; Bartoloni G; Farinella Z; Cordaro S; Scapagnini U
    Endocrinology; 1989 Aug; 125(2):1025-36. PubMed ID: 2546732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines.
    Emons G; Ortmann O; Becker M; Irmer G; Springer B; Laun R; Hölzel F; Schulz KD; Schally AV
    Cancer Res; 1993 Nov; 53(22):5439-46. PubMed ID: 8221683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines.
    Emons G; Schröder B; Ortmann O; Westphalen S; Schulz KD; Schally AV
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1458-64. PubMed ID: 8263128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoactivation enhances the concentration of luteinizing hormone-releasing hormone peptide and its gene expression in human peripheral T-lymphocytes.
    Azad N; La Paglia N; Jurgens KA; Kirsteins L; Emanuele NV; Kelley MR; Lawrence AM; Mohagheghpour N
    Endocrinology; 1993 Jul; 133(1):215-23. PubMed ID: 8319570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 2-week combination therapy with the luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6, des-Gly-NH2(10)]LHRH ethylamide and the antiandrogen flutamide on prostate structure and steroid levels in the dog.
    Lacoste D; Dubé D; Bélanger A; Labrie F
    Mol Cell Endocrinol; 1989 Dec; 67(2-3):131-8. PubMed ID: 2693158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of [hydroxyproline9]luteinizing hormone-releasing hormone and its smallest precursor forms in immortalized luteinizing hormone-releasing hormone-secreting neurons (GT1-7), and evaluation of their mode of action on pituitary cells.
    Gautron JP; Poulin B; Kordon C; Drouva SV
    Mol Cell Endocrinol; 1995 Apr; 110(1-2):161-73. PubMed ID: 7672446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of luteinizing hormone releasing hormone and its mRNA in human endometrial cancer cell lines.
    Irmer G; Bürger C; Ortmann O; Schulz KD; Emons G
    J Clin Endocrinol Metab; 1994 Sep; 79(3):916-9. PubMed ID: 8077383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.